Ibuprofen Suspension Bioequivalence Study

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 2, 2015

Primary Completion Date

August 25, 2015

Study Completion Date

August 25, 2015

Conditions

Healthy Volunteer Study

Interventions

DRUG

Nurofen for Children®

DRUG

Algifor Dolo Junior®

Trial Locations (1)

Reckit Benckiser, Hull

All Listed Sponsors

lead

Reckitt Benckiser Healthcare (UK) Limited

INDUSTRY

NCT02503085 - Ibuprofen Suspension Bioequivalence Study | Biotech Hunter | Biotech Hunter